
Cheng Zhang, Character Biosciences CEO
Ophthalmology startup Character Biosciences gets $93M for genetics-based approach
Seven years into its existence, Character Biosciences is ready to enter the clinic with a pair of experimental medicines targeting a bustling area of ophthalmology …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.